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mapping VT (n = 1). In 3 patients ICD was implanted after ablation.
7 patients (87.5%) survived to discharge and are on regular follow
up (19.71  12.08 months) and none had any recurrence of VT or
ICD shocks since discharge. 1 patient expired due to pulmonary
complications 2 weeks after ablation.
Conclusion: ES is a challenging clinical problem. VT ablation and
stellate ganglionectomy has improved outcomes.
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Introduction: Improve SCA aims to ﬁnd a group of primary pre-
vention ICD patients with VT/VF treatment rates similar to sec-
ondary prevention patients. The study intends to enroll 4800
patients worldwide, with approximately 1600 coming from India.
We hypothesized rates of ICD implant vary by country.
Methods: At baseline, patients were identiﬁed as either primary or
secondary prevention. Primary prevention patients who met at
least one of four risk criteria (syncope, NSVT, frequent PVCs, or
LVEF < 25%)were identiﬁed as 1.5 patients, thosewho did notmeet
criteria are labeled 1.0 patients. The decision to implant an ICDwas
at the patient's discretion, e.g., to choose whether or not they
wished to receive a device implant.
Results: Through 14 months of study enrollment, 236 out of 994
patients enrolled were from India. The overall average age was
59.0  13.6, with a 74%/26%male/female distribution. Patients had
been enrolled from 12 different countries. Of those enrolled, 825
(158 in India) had complete baseline/implant data, 31% (16% in
India) of whom were secondary prevention patients. Of the pri-
mary prevention patients, 70% (65%) were in the 1.5 category. As
expected, the rate of implant in India varied depending on the
indication, with 92% of secondary prevention patients, 31% of 1.5
patients, and 22% of 1.0 patients choosing implant.
Conclusion: Initial enrollment in the improve SCA study, con-
ducted in emerging countries, has seen a large percentage of
primary prevention patients. Percent of patients declining ICD
therapy varies by indication and country. In India, a greater num-
ber of primary prevention patients have declined implant.
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Introduction: Conduction system disorder is one of the leading
cause of morbidity and mortality in India specially in the eastern
part. Most of the patients present to the emergency department
with bradycardia and asystole and they need to be treated imme-
diately by temporary pacemaker implantation followed by implan-
tation of permanent pacemaker. Although ﬂuoroscopy is needed
for the very purpose, but sometimes due to emergency situation
temporary transvenous pacemaker are implanted without ﬂuoro-
scopy at bedside Guidewire-associated complications can occur
during the process of sheath insertion, eg: kinking, looping, and
knotting. Rarely the wire can be dislodged in the vasculature,
where it can cause vessel damage, major hemorrhage, or embo-
lization to vital structures. We report a case of J-guidewire dis-
lodged accidentally to the right atrium. The guidewire was
successfully withdrawn with the help of a pigtail catheter under
ﬂuoroscopic guidance. The patient remained hemodynamically
stable throughout the procedure. In this way, we averted an open
surgical procedure.
Case report: A 65-year-old diabetic male, known case of CAD, post
CABG presented with 2 episodes of syncope to the emergency
department. His pulse was 20/min and BP was 40 mmHg (systolic).
ECG showed complete heart block. As the cathlab was occupied by
ongoing procedure, so, temporary pacemaker was implanted
through femoral vein immediately after admission at the bedside
and patient became stable. Next day, he was taken to cathlab for
permanent pacemaker implantation. On OT table, when we
checked the position of temporary pacemaker lead, we were sur-
prised to see that the short J-guidewire is present inside the heart;
curved upper end being at the top of right atrium. To avoid open
cardiac surgery, we decided to retrieve the wire under ﬂuoroscopic
guidance. Unfortunately snare was not available, so we tried to
apply some ideas so that it can be removed under ﬂuoroscopy.
First, we removed the temporary pacemaker lead as the patient
was in sinus rhythm at that time. Then, we tried to insert a long
femoral sheath over the lower end of the J-wire with the intent to
insert a PTCA wire and balloon and subsequently to remove the
wire by inﬂating the balloon and pressing the wire against the
inner wall of the sheath. But we failed in the ﬁrst step. Then, we
tried with a handmade snare out of a PTCA wire; again we failed.
Next, we inserted another J-wire and tried to wrap it around the
dislodged wire; but whenever, we tried to pull it, it slipped away.
Finally, we introduced a 5 F pigtail catheter, andwrapped it around
the J-wire. With gentle pull, it came down from right atrium and
the lower end engaged in femoral vein. With a small incision over
femoral vein, we removed the J-wire and we averted an open
surgical procedure.
Discussion: Complete heart block with syncope is one of the
important cardiac emergency and need to treated with immediate
transvenous temporary pacemaker implantation. Although tem-
porary pacemaker lead implantation is a simple procedure, one
should be extremely careful. Preferably, it should be done in the
cathlab. Depending upon personal preferences, it can be done
through femoral, jugular and subclavian vein. After the procedure,
one should always check that the needle, J-wire, dilator is dis-
carded. Snare should always be available at the cathlab. Innovative
ideas can avert many complications. One should have patience
during any complication.
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Introduction: Symptoms caused by sinus node dysfunction (SND),
the most common bradyarrhythmia, can only be mitigated by
permanent cardiac pacing. Yet pacemaker therapy remains under-
utilized in developing regions of the world. The IMPROVE Brady
study is the ﬁrst prospective evaluation aimed to identify factors
related to therapy prescription in underserved regions.
Methods: Patients presenting with symptoms such as fatigue,
shortness of breath, and syncope, a heart rate of ≤50 beats per
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 7 2 – s 8 2 S75
minute, and without AV block were enrolled and followed in effort
to identify the proportion diagnosed with SND and subsequently
treated. Rationale for not receiving pacemaker therapy for SND
was recorded. A multivariable logistic regression assessed the
association between baseline characteristics and probability of
receiving an implant after SND diagnosis.
Results: Patients (n = 510) enrolled from India and Bangladeshwere
more likely to be male (78%), with a mean age of 58  15 years, and
a history of Sinus brady/SND (63%) at baseline. Through 8.4  8.0
months follow-up, 369 received an SND diagnosis and 61 (17%) of
patients were implanted with a pacemaker. Insurance-related
issues (34%), physician preference for other medical management
(23%), patient not agreeing that their condition warranted implant
(22%), and physician determining patient was not indicated (19%)
were the dominant reasons for declining a pacemaker. Higher age,
female gender, and syncopal or pre-syncopal symptoms 30 days
prior to baseline visit were associated with a higher probability of
implant (Table 1).
Conclusions: In a real-world assessment in South Asia, 1 in 6
patients diagnosed with symptomatic SND receive a permanent
cardiac pacemaker with less than half of declines being related to
insurance reasons. Younger males were the least likely to receive
therapy. A process improvement initiative is warranted to improve
the diagnosis and therapy application.
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Introduction: The prevalence of ventriculoatrial (VA) conduction
varies from nearly 20% to 90%, depending on the population
studied. This ﬁgure is based on small studies done for different
arrhythmias. However, the prevalence of VA conduction in struc-
turally normal hearts has not been well documented to the best of
our knowledge.
Methods: Data was recorded in 47 consecutive adults without
structural heart disease, undergoing electrophysiological study
and ablation for tachyarrhythmias. AV nodal re-entrant tachycar-
dia was excluded. All procedures were performed under local
anesthesia in an anti-arrhythmic drug free state. The measure-
ments for this study were performed after ablation. The PR, QRS,
AH and HV intervals, atrioventricular Wenckebach point (AVWP)
and anterograde effective refractory period of atrioventricular
node (AVNERP) were measured. VA conduction was assessed; if
absent, it was retested after isoprenaline. VA Wenckebach point
(VAWP) and retrograde effective refractory period (VAERP) were
recorded in patients showing VA conduction. Age, gender, PR, AH,
HV, AVNERP and AVWP were assessed as correlates/predictors of
VA conduction. One-sided Fisher's exact test and unpaired t test
were used as necessary.
Results: The age of the patients was 37  13 years. Twenty-one
(45%) patients weremen and 26 (55%) were women. VA conduction
was present in 26 (55%) patients at baseline. Of the remaining 21
patients, 16 patients showed VA conduction after isoprenaline.
Only 5 (11%) patients failed to reveal VA conduction even after
isoprenaline. Of the variables studied, only the HV interval was
signiﬁcantly different (36.6  10.6 vs 49.2  5.8 ms, p < 0.003) in
patients with VA conduction. All parameters of patients with
baseline VA conduction and those with VA conduction only after
isoprenaline were similar, except the QRS duration which was
signiﬁcantly higher in patients with baseline VA conduction (90
 20.9 vs 80.1  8.4 ms, p < 0.05).
Conclusions: VA conduction is present in 55% of people with
structurally normal hearts. Isoprenaline enables VA conduction
in another 34% of these subjects. Age, gender and indicators of
AV conduction such as PR interval, AH, AVNERP and AVWP do
not differ whether VA conduction is present or absent. The
HV interval is longer in patients without VA conduction.
The QRS duration is more in patients with VA conduction at
baseline as compared to those with VA conduction only after
isoprenaline.
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Idiopathic ventricular arrhythmia
 10% of ventricular arrhythmias occurs in structurally normal
heart
 Classiﬁed into three groups:
 Outﬂow tract ventricular arrhythmia
 Idiopathic left ventricular tachycardia (ILVT)
 Automatic ventricular tachycardia
Outﬂow tract arrhythmia – Our experience 2011–2013
 Total OT-VA cases: 18
 Male:Female: 6:12
 Age: 22–63 years
 Co morbidity: HTN 6 cases
 Symptoms: Palpitation and giddiness
 ECG in SR: Normal in 15 and incomplete RBBB in 3
 ECG in VA: LBBB morphology and inferior axis and transition at
V4 – RVOT
 Clinical presentation: sustained VT-7 and PVC's and
NSVT-11
 Holter: PVC's ranges from 16,600 to 59,000/24 h (15–50%)
 Echo: LV dysfunction-5 (2 old MI)
 MRI with contrast: 6 patients – 2 ARVC
Mapping system:
 CARTO 3 system-8
 Ensite Array balloon-5
 Ensite velocity-4 and 2D-1
Table 1 – Multi-variable analysis of factors affecting
pacemaker implant probability.
Parameter OR (95% CI) p-Value
Age (per year) 1.03 (1.01, 1.06) 0.005
Female gender 2.41 (1.21, 4.79) 0.01
Contributes ﬁnancially
to household
0.58 (0.29, 1.14) 0.11
Syncope/presyncopal
symptoms 30 days prior
to baseline visit
4.35 (2.26, 8.35) <0.0001
Education (vs none formal)
Primary 0.96 (0.32, 2.86) 0.27
Secondary/High School 1.65 (0.54, 5.09) 0.38
College/Graduate 1.78 (0.59, 5.38) 0.23
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